Driving Scientific Excellence
Research & Innovation
R&D Scientist

Innovation with a One Health Vision

At Auxillion Lifecare, Research & Development is at the heart of our growth strategy. R&D is not just a support function - it is the engine that shapes our future portfolio across human, veterinary healthcare and wellness sectors. We focus on smart, science-led formulation development, with an emphasis on quality, stability and patient/animal convenience.

Our R&D efforts are aligned with global expectations, preparing us for future USFDA- and EU-compliant manufacturing.

By integrating human and veterinary R&D under one roof, Auxillion supports the “One Health” approach—recognising the link between human, animal and environmental health. Our goal is to build a sustainable, innovation-led pipeline that delivers real therapeutic value to patients, animals and healthcare partners worldwide.

Our R&D Capabilities

TYPE: OSD // DATA_SET_01
Oral Solid Dosage

ORAL SOLID DOSAGE EXPERTISE

Our core R&D strength lies in developing advanced oral solid dosage forms, with a focus on tablets, capsules, pellets, bilayer tablets and oral strips. We design each product for optimized bioavailability, stability and patient/animal convenience.

TYPE: LIQ // DATA_SET_02
Oral Liquids

ORAL LIQUIDS: SYRUPS & SUSPENSIONS

We specialize in formulation & development of palatable and stable oral syrups and suspensions. Formulations are designed for good palatability, dose accuracy, guaranteeing long-term chemical stability and uniform API distribution and patient-friendly viscosity.

TYPE: INJ // DATA_SET_03
Parenteral

PARENTERAL: SOLUTIONS & INJECTABLE SUSPENSIONS

Our injectable R&D unit develops critical sterile solutions and suspensions, with advanced capabilities in Long-Acting Modified Release (LAMR) injectable suspensions. This focus aims to reduce dosing frequency and enhance therapeutic outcomes.

TYPE: OPT // DATA_SET_04
Ophthalmic

OPHTHALMIC SOLUTIONS & SUSPENSIONS

Dedicated expertise in developing sterile ophthalmic preparations. R&D emphasizes strict control over pH, osmolarity, and particle size to maximize patient comfort, clarity, therapeutic action, and drug penetration.

Beyond The Pill, Next-Generation Oral Strips

These thin, mouth-dissolving strips are designed to offer significant patient benefits by providing:

Disintegrate quickly without water
Fast-dissolving
On-the-go dosing needs
Convenient, and needle-free alternative
Ideal for pediatric and geriatric patients
As well as those with dysphagia

// Active_Development: Diverse_Portfolio_Protocol

Antihypertensives and Antidiabetics

For enhanced daily compliance

Antidepressants and Anti-vomiting

Ideal for rapid onset of action

Erectile Dysfunction, Antacids, & Supplements

Like vitamin D3

"This commitment to oral strip technology represents our dedication to improving patient experience and therapeutic effectiveness through modern, patient-centric dosage forms."

Auxillion aims to build a differentiated oral strip portfolio that combines comfort, precision dosing and better adherence.

Effective Eye Drops: Overcoming Ocular Barriers

Developed a focused eye-care line for conjunctivitis and glaucoma in the form of sterile eye drops, solutions and suspensions.

Conjunctivitis Care

For conjunctivitis, these formulations are designed to deliver rapid relief with high comfort and quickly reduce redness, irritation and discharge while keeping the eye comfortable and well-lubricated, helping patients return to clear, comfortable vision sooner.

Glaucoma Management

For glaucoma, our drops aim to support consistent control of intraocular pressure with stable, well-tolerated formulations that are easy to use long term, improving adherence and helping protect vision over time. Through this targeted innovation, Auxillion delivers practical, clinic-ready eye-care options for patients and eye-care professionals.